Spirit Pharmaceuticals

Form 483 issued January 25, 2017 · Ronkonkoma, New York

Inspection
Jan 18 – Jan 25, 2017
Investigator
Robert C. Horan
Observations
2
Pages
3
FEI number
3011773798

In short: On January 25, 2017, FDA issued a Form 483 with 2 observations to Spirit Pharmaceuticals in Ronkonkoma, New York (FEI 3011773798) after an inspection that ran Jan 18 – Jan 25, 2017. The investigator was Robert C. Horan. Most observations concern quality system and facilities & equipment; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

Quality system and facilities & equipment account for 2 of 2 observations.

Quality system1
Facilities & equipment1

Most cited: 21 CFR 211.22(d) (1×) · 211.68(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    Routine checking of electronic equipment is not performed according to a written program designed…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Spirit Pharmaceuticals?

FDA listed 2 observations on this Form 483, mostly about quality system and facilities & equipment. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Spirit Pharmaceuticals?

Robert C. Horan is named on this Form 483, for the inspection of Jan 18 – Jan 25, 2017. Each investigator has a profile showing what they cite most.

When was Spirit Pharmaceuticals inspected by FDA?

The inspection ran Jan 18 – Jan 25, 2017, and the Form 483 is dated January 25, 2017.

How do I get the full Form 483 for Spirit Pharmaceuticals?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free